Csizmar, C. M., Gurney, M., Kanagal-Shamanna, R., Chien, K., Hammond, D., Lasho, T. L., Finke, C. M., Dean, C., Natu, A., Mangaonkar, A. A., Al-Kali, A., Gangat, N., Tefferi, A., Alkhateeb, H., Garcia-Manero, G., Komrokji, R. S., Ali, N. A., Padron, E., Montalban-Bravo, G. and Patnaik, M. M. (2020) “<i>ASXL1/TET2</i> genotype-based risk stratification outperforms <i>ASXL1</i&gt; mutational impact and is independent of mutant variant allele fractions in chronic myelomonocytic leukemia”, Haematologica. Pavia, Italy. doi: 10.3324/haematol.2024.285410.